Anti-idiotypic monoclonal antibody cancer vaccines Journal Article


Author: Chapman, P. B.
Article Title: Anti-idiotypic monoclonal antibody cancer vaccines
Abstract: Anti-idiotypic monoclonal antibodies (MAb) can mimic both protein and non-protein in antigenic epitopes. In animal models, and now in patients, it is possible to induce immune responses against tumor antigens using anti-idiotypic MAb vaccines. While it is not clear how the efficacy of anti-idiotypic MAb vaccines compares with the efficacy of vaccines constructed from antigen, there are two situations where anti-idiotypic vaccines have potential advantages: (1) when the antigen is not readily available in sufficient quantities or purity, and (2) when the antigen is a non-protein. Clinical trials are underway using anti-idiotypic MAb vaccines in both of these situations.
Keywords: mice; melanoma; immunity; vaccine; induction; ganglioside; tumor-associated antigen; immune-response; mimicry; molecular mimicry; antiidiotypic antibody; cancer; t-cell clones; gd3; internal image; anti-idiotypic antibody
Journal Title: Seminars in Cancer Biology
Volume: 6
Issue: 6
ISSN: 1044-579X
Publisher: Academic Press Inc., Elsevier Science  
Date Published: 1995-12-01
Start Page: 367
End Page: 374
Language: English
ACCESSION: WOS:A1995TV11700007
DOI: 10.1016/1044-579x(95)90006-3
PROVIDER: wos
PUBMED: 8938275
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman